Urologix, Inc. announced preliminary unaudited revenue results for the third quarter ended March 31, 2014. Third quarter fiscal year 2014 revenue totaled $3.4 million, down 12% compared to the second quarter of fiscal year 2014 and down 18% compared to the prior year's results.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | -.--% |
2016 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
2015 | Urologix Conducting A Strategic Review | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.13T | |
+7.01% | 22TCr | |
+9.85% | 19TCr | |
+27.51% | 15TCr | |
+31.79% | 11TCr | |
-0.91% | 6.28TCr | |
+13.93% | 5.23TCr | |
+1.85% | 4.93TCr | |
+0.30% | 3.54TCr | |
+22.28% | 3.09TCr |
- Stock Market
- Equities
- ULGX Stock
- News Urologix, Inc.
- Urologix, Inc. Announces Preliminary Unaudited Revenue Results for the Third Quarter Ended March 31, 2014